Navigator Medicines, Inc. funding history

By Find your role first team · October 9, 2026

Navigator Medicines, Inc. has filed 1 Form D offerings with the SEC. The latest reports $10.0M sold.

Every Form D filing

Named in the latest filing

• Tausif ButtExecutive Officer, Director, Promoter
• Stephen ThomasExecutive Officer, Director, Promoter
• Scott ForrestExecutive Officer
• Wouter JoustraDirector
• Khurem FarooqDirector
• Mathias VintherDirector
• Kristie GrebeExecutive Officer

From SEC Form D filings. Rounds are our estimate from the amount sold; filings carry no valuation. All filings on SEC EDGAR